<unk>  is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).
Maftivimab
Atoltivimab
Odesivimab
Regdanvimab
Sotrovimab
Nirsevimab
Faricimab
Obiltoxaximab